Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report) has received an average recommendation of “Moderate Buy” from the eleven research firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $124.38.
BLLN has been the subject of several recent research reports. Piper Sandler decreased their price objective on Billiontoone from $140.00 to $130.00 and set an “overweight” rating for the company in a report on Tuesday, November 10th. Weiss Ratings raised shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research note on Monday, November 9th. Zacks Research upgraded shares of Billiontoone from a “strong sell” rating to a “hold” rating in a report on Friday, October 2nd. BTIG Research reiterated a “buy” rating and set a $130.00 target price on shares of Billiontoone in a report on Thursday, November 5th. Finally, JPMorgan Chase & Co. raised their target price on shares of Billiontoone from $130.00 to $135.00 and gave the company an “overweight” rating in a research report on Thursday, November 5th.
View Our Latest Analysis on BLLN
Insider Transactions at Billiontoone
Institutional Investors Weigh In On Billiontoone
Institutional investors have recently bought and sold shares of the company. Sei Investments Co. purchased a new stake in shares of Billiontoone in the first quarter worth about $1,058,000. The Manufacturers Life Insurance Company raised its position in Billiontoone by 151.8% during the first quarter. The Manufacturers Life Insurance Company now owns 30,506 shares of the company’s stock valued at $2,408,000 after acquiring an additional 18,389 shares in the last quarter. Wasatch Advisors LP raised its position in Billiontoone by 40.2% during the second quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock valued at $62,160,000 after acquiring an additional 148,446 shares in the last quarter. Bank of America Corp DE lifted its holdings in Billiontoone by 8,603.4% in the first quarter. Bank of America Corp DE now owns 12,707 shares of the company’s stock valued at $1,003,000 after acquiring an additional 12,561 shares during the period. Finally, Perceptive Advisors LLC lifted its holdings in Billiontoone by 26.1% in the first quarter. Perceptive Advisors LLC now owns 91,812 shares of the company’s stock valued at $7,248,000 after acquiring an additional 19,000 shares during the period.
Billiontoone Price Performance
Shares of BLLN stock opened at $105.15 on Monday. Billiontoone has a twelve month low of $61.96 and a twelve month high of $150.44. The stock has a market capitalization of $5.02 billion and a price-to-earnings ratio of 114.29. The stock has a fifty day simple moving average of $106.99 and a two-hundred day simple moving average of $97.74. The company has a current ratio of 11.25, a quick ratio of 10.89 and a debt-to-equity ratio of 0.16.
About Billiontoone
BillionToOne is a molecular diagnostics company that develops and provides genetic testing for prenatal care and cancer care. Its tests use the company’s molecular counting technology to detect and measure genetic material in patient samples. In prenatal care, BillionToOne offers screening for chromosomal conditions and certain inherited single-gene disorders. Its UNITY platform includes tests designed to assess fetal risk using a pregnant patient’s blood sample. The company also provides oncology testing, including services designed to help characterize tumors and detect cancer-related genetic material.
Further Reading
- Five stocks we like better than Billiontoone
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.
